<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01091623</url>
  </required_header>
  <id_info>
    <org_study_id>001/2005</org_study_id>
    <nct_id>NCT01091623</nct_id>
  </id_info>
  <brief_title>Effects of Strength Training in Combination With Endurance Training on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <brief_summary>
    <textblock>
      Background. Exercise intolerance is one of the most devastating consequences of chronic&#xD;
      obstructive pulmonary disease (COPD). Abnormalities in peripheral muscle function such as&#xD;
      weakness and reduction in oxidative enzyme activities are commonly found in these patients&#xD;
      and may contribute to exercise intolerance.To evaluate whether a systemic weightlifting&#xD;
      exercise may improve exercise capacity better than endurance training, or a combined training&#xD;
      is more effective, the investigators compared three different training regimens, endurance&#xD;
      training alone, systemic weightlifting training alone or a combination of both endurance and&#xD;
      weightlifting training.&#xD;
&#xD;
      Methods.36 patients with stable COPD will be evaluated before and after a 4 month training&#xD;
      program. Each evaluation include a stepwise exercise test on an ergocycle up to the&#xD;
      individual maximal capacity during which minute ventilation (VE), oxygen consumption (VO2),&#xD;
      carbon dioxide production (VCO2), and arterial lactic acid concentration will be measured and&#xD;
      the peripheral muscle strength will be determined with the one repetition maximum for eight&#xD;
      different muscle groups. Percutaneous needle muscle biopsy from the M.vastus lateralis will&#xD;
      be performed before and after the training period in order to determine the fiber-type&#xD;
      proportions. Patients are assigned to one of the following three groups (1) endurance&#xD;
      training consisted of 20 min exercise sessions on a calibrated ergocycle two times a week,&#xD;
      with a target training intensity at 60% of individual maximum oxygen uptake, (2) systemic&#xD;
      weightlifting training two times a week with eight different exercises, each session consist&#xD;
      of 15 repetitions of each muscle group, (3) combination of endurance training and systemic&#xD;
      weightlifting training.&#xD;
&#xD;
      Statistical analysis. Baseline data for all patients enrolled in the study will be compared&#xD;
      by one-way analysis of variance for the three study groups. Results before and after training&#xD;
      will be analyzed by two- way analysis of variance.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2005</start_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>increase of exercise capacity</measure>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>strength training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>endurance training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>combined training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>training</intervention_name>
    <arm_group_label>strength training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>training</intervention_name>
    <arm_group_label>endurance training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>training</intervention_name>
    <arm_group_label>combined training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. age: 40-75 years&#xD;
&#xD;
          2. mild to moderate COPD patients according to the staging schemata of the austrian&#xD;
             society of lung and tuberculosis disease (Ã–GLUT)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. acute infection&#xD;
&#xD;
          2. reduced left ventricular function&#xD;
&#xD;
          3. myocardial infarction&#xD;
&#xD;
          4. stroke&#xD;
&#xD;
          5. severe pulmonary hypertension (mpap&gt;40mmHg)&#xD;
&#xD;
          6. insufficient treated hypertension RR&gt;160/95) (participation with sufficient treatment&#xD;
             )&#xD;
&#xD;
          7. severe cardiac arrhythmia&#xD;
&#xD;
          8. malignant diseases&#xD;
&#xD;
          9. severe osteoporosis&#xD;
&#xD;
         10. nicotine abuses&#xD;
&#xD;
         11. other severe chronic diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>May 2005</verification_date>
  <study_first_submitted>March 23, 2010</study_first_submitted>
  <study_first_submitted_qc>March 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2010</study_first_posted>
  <last_update_submitted>March 23, 2010</last_update_submitted>
  <last_update_submitted_qc>March 23, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2010</last_update_posted>
  <keyword>improvement of exercise capacity in patients with COPD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

